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Abstract
Angelman syndrome (AS) is a neurobehavioral disorder associated with mental retardation, absence of language
development, characteristic electroencephalography (EEG) abnormalities and epilepsy, happy disposition, movement or
balance disorders, and autistic behaviors. The molecular defects underlying AS are heterogeneous, including large maternal
deletionsof chromosome 15q11–q13(70%), paternal uniparentaldisomy (UPD) of chromosome 15 (5%),imprinting mutations
(rare), and mutations in the E6-AP ubiquitin ligase gene UBE3A (15%). Although patients with UBE3A mutations have a wide
spectrum of neurological phenotypes, their features are usually milder than AS patients with deletions of 15q11–q13. Using a
chromosomal engineering strategy, we generated mutant mice with a 1.6-Mb chromosomal deletion from Ube3a to Gabrb3,
which inactivated the Ube3a and Gabrb3 genes and deleted the Atp10a gene. Homozygous deletion mutant mice died in the
perinatal period due to a cleft palate resulting from the null mutation in Gabrb3 gene. Mice with a maternal deletion (m2/p+)
were viable and did not have any obvious developmental defects. Expression analysis of the maternal and paternal deletion
mice confirmed that the Ube3a gene is maternally expressed in brain, and showed that the Atp10a and Gabrb3 genes are
biallelically expressed in all brain sub-regions studied. Maternal (m2/p+), but not paternal (m+/p2), deletion mice had
increased spontaneous seizure activity and abnormal EEG. Extensive behavioral analyses revealed significant impairment in
motor function, learning and memory tasks, and anxiety-related measures assayed in the light-dark box in maternal deletion
but not paternal deletion mice. Ultrasonic vocalization (USV) recording in newborns revealed that maternal deletion pups
emitted significantly more USVs than wild-type littermates. The increased USV in maternal deletion mice suggests abnormal
signaling behavior between mothers and pups that may reflect abnormal communication behaviors in human AS patients.
Thus,mutantmicewitha maternaldeletionfromUbe3atoGabrb3provide anASmousemodelthatismolecularlymoresimilar
to the contiguous gene deletion form of AS in humans than mice with Ube3a mutation alone. These mice will be valuable for
future comparative studies to mice with maternal deficiency of Ube3a alone.
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Introduction
Angelman syndrome (AS) is a neurodevelopmental disorder
associated with severe mental retardation, absence of language
development, characteristic EEG abnormalities and epilepsy,
happy disposition, movement disorders, and autistic features [1].
The molecular defects underlying AS are heterogeneous. About
70% of AS patients have a large chromosomal deletion of 15q11–
q13, exclusively of maternal origin. Paternal uniparental disomy
(UPD) of chromosome 15 is found in ,5% of AS patients.
Mutations of the E6-AP ubiquitin ligase gene (UBE3A)o n
maternal chromosome 15 are found in about 15% of AS patients.
Rarely, a microdeletion in the region designated as an imprinting
center is also found in some cases of AS. The finding of loss-of-
function mutations in the maternal UBE3A gene in patients with
typical features of AS indicates that maternal deficiency for
UBE3A is responsible for the major clinical manifestations [2,3].
In addition, maternal, but not paternal, duplication of 15q11–q13
has been reported in about 1–2% of idiopathic autism spectrum
disorder patients [4]. Recently, a small duplication covering from
ATP10A to GABRB3 was reported in one autism patient [5]. At
the molecular level, AS patients with a large chromosomal
deletion of 15q11–q13 have deficiency of the maternally
expressed UBE3A gene and possibly of ATP10A in brain, and
they are haploinsufficient for many other genes with biallelic
expression within the 6-Mb deleted interval. These biallelically
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GABRG5, and GABAG3 telomeric of UBE3A,a n dCYFIP1, NIPA1,
NIPA2, GCG5, WHCD1L1, and GOLGA8E at the centromeric end
of the deletion in patients with a larger class I deletion [6,7].
Reports have suggested that the ATP10A gene is maternally
expressed in humans [8,9]. One report found that ATP10A
exhibits imprinted expression in brain but biallelic expression in
non-neuronal tissues [9]. Another study reported imprinted
expression of ATP10A in lymphoblasts as well as brains [8].
The most recent report found that ATP10A was expressed
biallelically in brain in the majority of individuals examined while
a small percentage exhibited variable monoallelic expression but
not strictly maternal allele-specific. Monoallelic expression
appeared to be favored by female gender [10]. Reports of
imprinting status of the mouse ortholog of ATP10A were also not
consistent. One report indicated that Atp10a is maternally
expressed in hippocampus and olfactory bulb [11], while two
other studies found that Atp10a is biallelically expressed in all
tissues [12,13]. Similarly, there were reports suggesting paternal,
maternal, and biallelic expression of GABRB3 in humans and
mice using different experimental designs [14,15,16]. A recent
report also suggested greatly reduced levels of the Gabrb3 subunit
in the brain of male mice with a maternally transmitted Gabrb3
mutation but not in male mice with paternal origin of the same
mutation [17].
In humans, analyses of genotype and phenotype correlation
among AS patients with different classes of molecular defects have
been reported [18,19]. These analyses have revealed that AS
patients with large chromosome deletions of 15q11–q13 have
more severe phenotypes than AS patients with UBE3A mutations,
paternal UPD, and imprinting mutations. In addition, there were
early reports suggesting that loss-of-function UBE3A mutations,
paternal UPD of chromosome 15, or imprinting mutations in AS
were associated with relatively milder epilepsy while AS patients
with a deletion of chromosome 15q11–13 had more severe
epilepsy [20]. However, other studies found no genotype-
phenotype correlation for EEG abnormalities and epilepsy among
AS patients with different genotypes [21,22]. One caveat of these
studies was the relative small sample size which might bias the
results and conclusion.
We have previously characterized an AS model with a null
mutation of the Ube3a gene. Mice with maternal deficiency of the
Ube3a gene recapitulated the brain-specific imprinted expression
[23,24]. Mice inheriting the Ube3a mutation maternally, but
not paternally, displayed phenotypes that resemble AS with
abnormal EEG and seizure activity, motor dysfunction, and
defects in contextual fear conditioning and hippocampal long-term
potentiation (LTP). These findings, together with a report by
others, indicate that mice with maternal deficiency of Ube3a are a
valid model for human AS with mutations in the UBE3A gene
[23,25].
Here we report generation and characterization of mutant mice
with a 1.6-Mb chromosomal deletion from Ube3a to Gabrb3. The
chromosomal deletion was generated by a chromosome engineer-
ing technique using cre/loxP and two halves of a Hprt
(hypoxanthine-guanine phosphoribosyl transferase) minigene as
described previously [26,27,28]. The deletion disrupted both the
Ube3a and Gabrb3 genes and also deleted the 1.6-Mb interval that
contains the Atp10a gene. Analyses of maternal (m2/p+), paternal
(m+/p2), and homozygous (m2/p2) deletion mice indicate that
mice with a maternal deletion from Ube3a to Gabrb3 provide an AS
mouse model that is molecularly more similar to the common
contiguous deletion form of AS, and thus valuable for future
comparative studies.
Results
Generation of mice with a chromosomal deletion from
Ube3a to Gabrb3
We used the chromosomal engineering technique to generate
mice with a large chromosomal deletion from Ube3a to Gabrb3 as
described previously [28,29] and in detail in the Methods section.
A total of three 129SvEv embryonic stem (ES) cell clones (P11A8,
P11B6, and P11H8) with a deletion from Ube3a to Gabrb3 were
confirmed by DNA Southern analysis and injected into C57BL/6J
blastocysts to obtain germline transmission. A total of 14 chimeric
mice were produced. Germline transmission was obtained from
ES cell clones P11A8 and P11B6 but not from P11H8. The Gabrb3
and Ube3a double targeted mutations without a deletion between
them were also obtained in germline (data not shown). Mice with a
deletion from Ube3a to Gabrb3 were identified by DNA genomic
Southern analysis using genomic probes flanking and within the
deletion interval as shown in the Figure 1E. Absence of signal in
DNA Southern analysis using a probe hybridizing within the
Atp10a gene indicated that the desired deletion was produced. A
PCR-based mouse genotyping protocol was also developed for
routine mouse colony management (data not shown). The
estimated size of the deletion from Ube3a to Gabrb3 was 1.6-Mb
(from 64846987 bp to 66527319 bp) based on the NCBI Build 37
assembly of mouse genome sequences (www.genome.ucsc.edu).
Both the Ube3a and Gabrb3 genes were disrupted as shown in
Figure 1D and confirmed by the RNA and protein analyses shown
in Figure 2A and 2B using fetus with a homozygous deletion. Mice
with a Ube3a single mutation have been characterized and
reported previously [23]. Mice with a Gabrb3 single mutation
and Ube3a and Gabrb3 double mutations produced from this
experiment have not been fully characterized. However, Gabrb3
mutant mice with a different mutation have been reported
previously by others [30]. Because of involvement of imprinting
in the region, a specific breeding scheme diagramed in
supplemental Figure S4 was followed to produce mice for
experiments described below.
Expression analysis of Ube3a, Atp10a, and Gabrb3 in mice
with a deletion from Ube3a to Gabrb3
We examined the parental origin of expression for Ube3a,
Gabrb3, and Atp10a in mice inheriting a paternal or maternal
deletion by RNA or protein analysis. Tissues from homozygous
deletion mice (m2/p2) were included in the analysis as controls.
The expression of Gabrb3 and Ube3a was examined by quantitative
immunoblot analysis while the expression of Atp10a was performed
by regular and real-time RT-PCR analysis because a specific
antibody against Atp10a was not available. Because of a report of
gender differences in monoallelic expression of Gabrb3 in mice and
ATP10A in humans [10,17], we performed the expression analysis
in both sexes of mice with a deletion from Ube3a to Gabrb3.
Different brain regions, including hippocampus, cerebellum, and
cerebral cortex, were dissected and compared to liver tissues to
determine if there were tissue-specific differences. The data from
all three brain regions were similar and only data from cerebellum
are shown. As shown in Figure 2A, the protein level of Ube3a in
m2/p+ mice was undetectable in cerebellum while the protein
level of Ube3a in m+/p2 mice was comparable to that in m+/p+
mice. The expression in the cerebral cortex of m2/p+ mice was
similar to cerebellum and almost exclusively maternal (data not
shown). The expression of Ube3a was readily detectable and similar
in liver tissues among m2/p+,m +/p2, and m+/p+ mice which
indicated biallelic expression of Ube3a in non-CNS tissues (data not
shown). These data are consistent with the previous reports that
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in the cerebral cortex was slightly different from the reports by
RNA in situ in UPD and Ube3a mutant mice [23,31]. The
expression of Gabrb3 was also readily detectable in m2/p+,m +/
p2, and m+/p+ mice in different brain regions in both males and
females by quantitative immunoblot analysis as shown in
Figure 2A. The level of Gabrb3 was 61.662.3% of wild-type in
the m2/p+ mice and 62.562.1% of wild type in the m+/p2 mice
for both sexes together which is slightly higher than 50% as
predicted for heterozygotes. The level of Gabrb3 in m+/p2 and
m2/p+ mice for males and females normalized to m+/p+
separately is summarized in Figure 2B. There was no significant
difference between m+/p2 and m2/p+ for males (n=5, p=0.75)
or females (n=5 and p=0.29). There was no evidence for
parental origin effect on the expression of Gabrb3 in the tissues
examined. Similarly, expression of Atp10a was readily detectable
by regular RT-PCR analysis in the cerebellum, cerebral cortex,
hippocampus, and liver tissues of m2/p+ and m+/p2 mice
(Figure 2C and 2D, and data not shown for hippocampus and liver
tissues). Among 8 (4 males and 4 females) m2/p+ and 7 m+/p2
mice (4 females and 3 males) analyzed by RT-PCR, we did not
observe the exclusively monoallelic expression of Atp10a in the
cerebellum and hippocampus that was described in human brains
[10]. To examine whether there was a quantitative or gender
specific imprinting expression of Atp10a, we also performed real-
time RT-PCR analysis for Atp10a in cerebellar tissues from m2/
p+ and m+/p+ mice of both sexes. Expression of Atp10a
normalized to the level of Gadph was 51.860.8% of wild type in
m2/p+ male mice and 50.660.4% of wild type in m2/p+ male
mice. There was no significant difference in the expression of
Atp10a between male and female m2/p+ mice (p=0.45, n=3).
These results indicate that the Atp10a gene is biallelically expressed
in the tissues examined although the possibility of cell-type specific
or developmental stage specific imprinting cannot be ruled out.
Perinatal lethality of mice with homozygous deletions
from Ube3a to Gabrb3
Heterozygous mice inheriting a deletion of either paternal or
maternal origin did not have any developmental defect. At 3
months of age, there was no difference in weight between m2/p+
Figure 1. Generation of mice with a deletion from Ube3a to Gabrb3 using chromosome engineering. A. Genomic maps for Ube3a and
Gabrb3 loci and design of targeting constructs (X, XbaI; H, HindIII; N, NotI; E, EcoRI; S, SacII; B, BamHI). The number in the rectangle indicates the exon
number. B & C. Genomic DNA Southern analysis for Ube3a or Gabrb3 targeted ES cell clones using 59-flanking probes and BamHI and HindIII
restriction enzymes respectively. D. A genomic map from Ube3a to Gabrb3 and a scheme for chromosome engineering using half of Hprt and Cre/loxP
strategy. The black bars indicate genomic probes used for DNA Southern analysis. E. Confirmation of a deletion from Ube3a to Gabrb3 by genomic
DNA Southern analysis using probes shown in D. The probes P1 and P4 hybridize outside of the deleted interval and the probes P2, P3, and PD
hybridize within the deleted interval. Four independent but indistinguishable ES cell clones (1–4, +/del) with a deletion were analyzed, and clone 5
(+ndel) was a Ube3a and Gabrb3 double targeted clone without a deletion. The DNA Southern analysis using the probe PD within the Atp10a gene
showed no signal in the DNA from homozygous deletion (del/del or m2/p2 in text) mice. ‘‘Co’’ was a control probe from the Snrpn gene that is
outside of deleted region in chromosome 7.
doi:10.1371/journal.pone.0012278.g001
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m+/p2 (20.860.9 g) and m+/p+ mice (20.960.8 g) (p=0.9).
There was no apparent difference between m2/p+ and m+/p2
mice by visual inspection. The lifespan of m2/p+ and m+/p2
mice was similar to their m+/p+ littermates. Homozygous mutant
mice with a deletion from Ube3a to Gabrb3 (m2/p2) were smaller
at birth and most died within 1 to 3 days after birth due to a cleft
palate and poor feeding (Figure 3A). At the weaning age, there was
a significantly skewed distribution of genotypes from Mendelian
inheritance (wild-type 20; heterozygotes 39; and homozygotes 2,
p,0.001) because of perinatal lethality. We carefully examined
each pup (n=12) that died perinatally. Nine of 12 dead pups had a
cleft palate, a representative example of which is shown in
Figure 3C. No other obvious structural defects were found in pups
with a homozygous deletion from Ube3a to Gabrb3. Functional
defects such as poor feeding may be considered as the cause of
perinatal death for pups without a cleft palate. Because it was
reported previously that a homozygous null mutation of Gabrb3
caused cleft palate [30], we also generated mice with single
homozygous Gabrb3 mutation for the purpose of comparison. A
cleft palate was found in 6 out of 7 pups with a homozygous Gabrb3
mutation. Two mice with a homozygous deletion from Ube3a to
Gabrb3 survived beyond the perinatal period but died at 24 and 28
days of age without a known cause. These two mice were ,20% of
smaller than their wild type littermates and without an apparent
cleft palate. To determine whether embryonic lethality was
associated with m2/p2 mice, a total of 19 pups from three
litters were dissected and genotyped at 16 days of gestational age.
The distribution of genotypes was not significantly different from
the expected Mendelian inheritance (wild-type 5; heterozygotes
10; and homozygotes 4, p.0.05). These data suggested that a
homozygous deletion from Ube3a to Gabrb3 did not cause
embryonic lethality and that the function of Atp10a is probably
not critical for embryonic development.
Spontaneous seizures and cortical discharges in mice
with a maternal deletion from Ube3a to Gabrb3
Spontaneous visible tonic-clonic seizures were observed in 21.4%
(6/28) of m2/p+ mice at 3–6 months of age but not in m+/p+ mice
(n=32) or m+/p2 mice (n=36) on the relatively homogenous
Figure 2. Expression analysis of Ube3a, Atp10a, and Gabrb3. A. Quantitative immunoblot analysis of Ube3a and Gabrb3 proteins in cerebellum.
The m+/p+ is for wild-type, the m2/p+ is for maternal deletion, the m+/p2 is for paternal deletion, and the m2/p2 is for homozygous deletion
fetus. The m+/p+ next to m2/p2 was fetal brain tissue; others tissues were from adult mice. There was no detectable expression of Ube3a in m2/p+
and m2/p2 mice indicating a null mutation in homozygotes and exclusively maternal expression of Ube3a. The expression of Ube3a in the m+/p2
mice was similar to m+/p+ mice. The expression of Gabrb3 was reduced but readily detectable in m+/p2 and m2/p2 mice for both males and
females compared to that of m+/p+ mice. The expression level of Gabrb3 normalized to b-actin is shown in 2B. The difference between m+/p+ and
m2/p+,m +/p+ and m+/p2 was significant (n=5, p,0.01) but there was no significant difference between m2/p+ and m+/p2 (n=5, p.0.05). 2C–E.
Expression analysis of Atp10a by regular and real-time RT-PCR analyses. The labels for genotype are the same as indicated in panel A. Data from
regular RT-PCR analysis for Atp10a using RNA isolated from cerebral cortex are shown in 2C and from the cerebellum in 2D. The expression of Hprt
was used as a control. The absence of RT-PCR product for Atp10a in the m2/p2 fetus indicated a null mutation of Atp10a in mice with a deletion. The
expression of Atp10a was detectable and not significantly different between m2/p+ and m+/p2 mice. The expression of Atp10a normalized to b-
actin by real-time RT-PCR analysis is shown in 2E. The level of expression of Atp10a in m2/p+ and m+/p2 was significantly lower than that of m+/p+
both in males and females (n=3, p,0.01) but there was no significant difference between m2/p+ and m+/p2 (n=3, p.0.05).
doi:10.1371/journal.pone.0012278.g002
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backcrossing to C57BL/6J mice. The frequency of seizure activity
in Ube3a to Gabrb3 maternal deletion mice was not different from
that of maternal Ube3a deficiency alone (21%) previously reported
[23]. To further characterize seizure activity, we performed chronic
electroencephalographic (EEG) recordings for 3 m2/p+,3m +/
p2, and 3 m+/p+ mice at 3–4 months of age. As shown in Figure 4,
EEG in m2/p+ mice showed a pattern beginning with sudden
isolated giant spike-wave discharges with no behavioral accompa-
niment, but then progressed to higher spike discharge frequencies,
at which point the mice displayed sustained behavioral arrest and
subtle myoclonic movements. These seizures lacked any tonic
posturing or postictal phenomenology, and the mice rapidly
resumed normal behavior (a sample video of recording is included
in the supplementary data, Video S1). Frequent generalized cortical
single interictal spike discharges were also present in m2/p+ mice
(not shown). We also performed EEG recording in maternal Ube3a
deficiency alone mice, and consistent with previous findings [23], an
abnormal EEG was observed (data not shown). Electrographic
seizures or discharges were not observed in m+/p2 and m+/p+
mice during the recording.
Behavioral analyses
We conducted a battery of behavioral tests for mice with a
maternal or paternal deletion from Ube3a to Gabrb3. Mice used for
behavioral tests were backcrossed to the C57BL/6J background
for more than 6 generations as described in Methods section and
diagramed in supplementary Figure S4. Behavioral tests included
the following: open field, light dark, rotarod, prepulse inhibition
(PPI), fear conditioning, Morris water maze, hot plate, and
ultrasonic vocalization (USV) recording. Mice at age 8–10 weeks
with a maternal deletion (m2/p+), paternal deletion (m+/p2),
and their wild type (m+/p+) littermates were used for the tests. A
total of 10 m2/p+ mice (5 males and 5 females) were compared to
a total of 16 m+/p+ (7 males and 9 females), and 11 m+/p2 mice
(6 males and 5 females) were compared to 10 m+/p+ (5 males and
5 females). For USV recording, newborn pups of 6 day old were
used for all genotypes. A total number of 18 m2/p+ pups (8 males
and 10 females) and 17 m+/p+ (7 males and 10 females); and 27
m+/p2 pups (12 males and 15 females) and 22 m+/p+ (12 males
and 10 females) were analyzed. Mice used for USV recording were
not used for other behavioral tests. Experimenters were blinded to
the genotype during testing, and tested mice were re-genotyped
after completion of testing. There was no significant difference
between males and females for these tests. Therefore, the results
were pooled for each test and described below.
Locomotor activity in the open-field
The open-field test was used to assess exploratory activity and
anxiety-related responses in a novel arena. The travel distance
during each testing block was similar for m2/p+ and m+/p2
mice and their m+/p+ littermates (p=0.12 for m2/p+ and
p=0.23 for m+/p2) (Figure S1A and S1B). There was no
significant difference in total travel distance between m2/p+ mice
and their m+/p+ littermates (Figure S1C; p=0.4), and there were
no differences in the center and total distance ratio (data not
shown). Similarly, there was no difference in total travel distance
between m+/p2 mice and their m+/p+ littermates (Figure S1C,
p=0.42).
Light-dark exploration
The light–dark exploration test was also used to assess anxiety-
related responses. The number of light-dark transitions was
significantly lower in m2/p+ mice than in m+/p+ littermates
(p=0.003) but not significantly different between m+/p2 mice
and m+/p+ littermates (p=0.8) (Figure 5A). In addition, m2/p+
mice stayed for a significantly longer time in the dark chamber
than their m+/p+ littermates (p=0.008) (Figure 5B). There was no
significant difference for light dark transition (p=0.25) and for the
percentage of time stayed in dark (p=0.32) between m+/p+ of
maternal and paternal groups. But the difference between m2/p+
and m+/p2 was significant (p=0.006). These results suggest
anxiety related behavior assayed by this task in m2/p+ mice when
compared to their m+/p+ littermates.
Rotarod test
There was no apparently abnormal gaits and weakness of limbs
in the maternal and paternal deletion mice. We then used rotarod
to study motor coordination and motor learning skills. As shown in
Figure 5C, m2/p+ mice performed significantly worse on an
accelerating rotarod than their m+/p+ littermates (p,0.0001).
The performance of m+/p2 mice was slightly worse than their
m+/p+ littermates but the results were not statistically significant
(Figure 5D, p=0.06).
Figure 3. Perinatal lethality and cleft palate in newborn mice with a homozygous deletion from Ube3a to Gabrb3 (m2/p2). A. Growth
retardation of 2-day-old pup with a homozygous deletion from Ube3a to Gabrb3. B & C. Cleft palate in a pup with a homozygous deletion from Ube3a
to Gabrb3. The black arrow points to the cleft palate in pup with a homozygous deletion (m2/p2).
doi:10.1371/journal.pone.0012278.g003
Altered Ultrasonic
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12278Hotplate
The hotplate test is an indicator of the sensitivity of animals to
painful stimuli. The time to the first hind-limb response is shown in
the Figure S1D. There was no significant difference between m2/
p+ mice and m+/p+ littermates (p=0.9). Similarly, there was no
difference between m+/p2 mice and their m+/p+ littermates
(p=0.46).
Prepulse inhibition (PPI)
As shown in Figure S2, there was no difference in maximal
startle response between m2/p+ mice and their m+/p+
littermates or between m+/p2 mice and their m+/p+ littermates.
There was a trend towards increased PPI in m2/p+ mice, but the
difference was not statistically significant (Figure S2B, p=0.17).
There was no significant difference between m+/p2 mice and
their m+/p+ littermates (Figure S2C; p=0.75).
Impaired contextual fear learning in maternal deletion
mice
Levels of freezing behavior for the contextual and auditory
cued conditioning fear tests are shown in Figure 6; m2/p+ mice
displayed a significantly lower level of freezing behavior in
contextual fear conditioning than their m+/p+ littermates
(p=0.03). A significant difference was not observed between
m+/p2 and m+/p+ mice for contextual fear conditioning
(p=0.59) (Figure 6A). There was no significant difference in
cued fear conditioning for either m2/p+ (p=0.31) or m+/p2
(p=0.58) mice compared to that of their m+/p+ littermates
(Figure 6B). These findings suggest that m2/p+ mice, but not
m+/p2 mice, have a selective impairment in fear conditioning
that is associated with the context or environment where the
shock occurred but not in cued fear conditioning.
Spatial learning in the Morris water maze task
We performed the Morris water maze test to evaluate spatial
learning and memory. As shown in Fig. 6C and 6D, both m2/p+
and m+/p2 mice had very similar performances on day 1 of
training which indicated the ability of swimming was comparable.
However, m2/p+ mice, but not m+/p2 deletion mice, took a
significantly longer time to locate the hidden platform in
subsequent trials (p,0.001 for m2/p+ and p=0.8 for m+/p2
mice). Probe trials were performed after the last trial to determine
if a different strategy of searching for the hidden platform was
used by mice with different genotypes. As shown in Figure 6E
and 6F, m+/p+ mice displayed a spatially biased search pattern
by making significantly more platform crossings in the target
quadrant 4 (p,0.001); a similar spatially biased searching pattern
was not observed in the m2/p+ mice (p=0.58). Post hoc analysis
for m+/p+ mice showed that the difference was significant only
between quadrant 3 and quadrant 4 (p,0.02), and between
quadrant 2 and quadrant 4 (p,0.01) (see Figure 6G). The m+/
p2 mice showed a searching pattern similar to m+/p+ mice (data
not shown).
Ultrasonic vocalizations (USVs)
We recorded ultrasonic vocalizations (USVs) for pups at age of
postnatal day 6, 8, 10, and 12 on three different beddings of clean,
mother’s, and stranger’s. The number of USVs recorded during a
period of five minutes for each day on different beddings was
analyzed separately (Figure S3) and together (Figure 7). When data
were analyzed separately on different days and beddings, it was
Figure 4. Abnormal EEG in mice with a maternal deletion from Ube3a to Gabrb3 (m2/p+). Multielectrode continuous EEG tracing shows
representative generalized rapid cortical spike seizure discharge in freely moving m2/p+ deletion mice. Top-bottom: temporal (T), parietal (P), and
occipital leads (O) alternating between left (L) and right hemisphere (R) indicated as LT, RT, LP, RP, LO, and RO. The six panels in the top tracing were
continued in the lower section. Single arrow indicates the onset of sudden isolated giant spike-wave discharges with no behavioral accompaniment,
and double arrow marks progression to higher spike discharge frequencies.
doi:10.1371/journal.pone.0012278.g004
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6 of the clean bedding than other beddings but not statistically
significant (p=0.07). However, the USV production of m2/p+
pups increased on subsequent days and was significantly higher
(p=0.034) on day 12 when compared to those of m+/p+ pups
(Figure S3). When the data on different beddings were analyzed
regardless of days, there was an overall trend of increased USVs in
m2/p+ pups compared to those of m+/p+ littermates in different
beddings. The difference was statistically significant in the group
recorded on the mother’s bedding (p=0.006), borderline in the
clean bedding group (p=0.046), but not significant in the
stranger’s bedding (p=0.12) (Figure 7A). There were no
significant differences between m+/p2 and m+/p+ pups in
different beddings (p=0.25) (Figure 7B). When the data were
analyzed on the different days regardless of beddings, there were
significantly increased USVs in m2/p+ pups compared to their
m+/p+ littermates (p=0.011). Post hoc analysis revealed that the
difference between m2/p+ and m+/p+ littermates was significant
on day 10 (p=0.02), borderline on day 12 (p=0.05), but not
significant on day 6 (p=0.81). The three-way (genotype vs bedding
vs day) mixed design ANOVA did not reveal significant interaction
among them (p=0.07). Similarly, two-way ANOVA did not reveal
significant interaction between genotype and bedding (p=0.15),
and genotype and day (p=0.29). There was no difference in USV
production between m2/p+ and m+/p+ pups (p=0.82), or
between m+/p2 and m+/p+ pups (p=0.3) recorded on clean
bedding in cold temperature on day 10 and day 12. These data
indicated a normal stress response and capability to produce the
USVs for both m2/p+ and m+/p2 pups. Thus, the abnormal
pattern of USV production observed in maternal deletion pups
may suggest abnormal signaling or communication behaviors
between mother and offspring.
Discussion
Application of chromosome engineering strategy to
model the human chromosome microdeletion
syndromes
Using Cre/loxP and Hprt minigene chromosome engineering
strategies, we have successfully generated and characterized
mutant mice with a 1.6-Mb chromosomal deletion in mouse
chromosome 7 corresponding to the critical region homologous to
that deleted in human Angelman syndrome. With the application
of array CGH (comparative genomic hybridization) in clinical
genetics practice, an increasing number of new microdeletion
syndromes are being characterized [32,33,34]. Together with
several examples reported previously by us and others [28,35], this
report emphasizes the value of this strategy in dissecting the
pathogenesis of human microdeletion syndromes using mouse
models [29]. We have observed a workable frequency of Cre
mediated recombination between two loxP sites that were 1.6-Mb
apart, and others have reported similar frequencies in other
chromosomal regions [36]. The challenge of this strategy is
probably still related to the difficulty of obtaining germline
Figure 5. Abnormal light-dark exploration and impaired rotarod performance in mice with a maternal deletion from Ube3a to
Gabrb3 (m2/p+) but not a paternal deletion (m+/p2). A & B. Light-dark transition. The m2/p+ but not m+/p2 mice showed a significantly
lower number of light and dark transitions, shown in A (p=0.003), and also spent significantly longer time in the dark chamber, shown in B
(p=0.008). There was no difference between m+/p+ of maternal and paternal group for both light-dark transition and percentage of time stayed in
dark. C & D. Rotarod performance. The time that m2/p+ mice remained on the accelerating rotarod was significantly shorter than m+/p+ littermates
for all trials, shown in C (p,0.0001). The overall performance of m+/p2 mice was slightly worse than that of m+/p+ littermates, but the difference
was not statistically significant, shown in D (p.0.05). * p,0.05.
doi:10.1371/journal.pone.0012278.g005
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electroporations during the procedure [28,37,38].
No evidence for allele-specific expression of the Atp10a
and Gabrb3 genes in mice
We have shown that there was no detectable expression of
Ube3a, Atp10A,a n dGabrb3 in homozygous deletion mice by
RT-PCR or immunoblot analysis, which indicated that the
deletion resulted in null alleles for all three genes. The
expression pattern of Ube3a in the cerebellum and hippocampus
in maternal deletion mice was consistent with previous reports
of exclusive maternal expression of Ube3a in these regions
[23,24]. We also observed that the expression in the cerebral
cortex was almost exclusively mater n a l .T h i si ss l i g h t l yd i f f e r e n t
from the previous report that the expression of Ube3a was
predominantly maternal and region specific in the cerebral
cortex by RNA in situ in UPD mice [23,31]. The discrepancy
could be due to the sensitivity of different techniques or
different mutations analyzed. Using mice carrying a paternal or
maternal deletion of Atp10a and Gabrb3,w ew e r ea b l et o
examine the parental origin of expression for Atp10a and Gabrb3
directly. Our analysis did not provide any evidence supporting
exclusive maternal expression of Atp10a but indicated biallelic
expression of Atp10a in the brain regions of mice examined by
quantitative RNA expression analysis. This analysis also did not
reveal monoallelic expression of Atp10a that was reported in a
small fraction of human brains and associated with gender [10].
Figure 6. Impaired learning and memory task in mice with a maternal deletion from Ube3a to Gabrb3 (m2/p+). A & B. Fear conditioning.
The m2/p+ but not m+/p2 mice showed significantly less freezing behavior in contextual fear conditioning (A) but not for cued fear conditioning.
C to G. Morris water maze task. The m2/p+ but not m+/p2 mice showed significantly longer escape latency than m+/p+ littermates (p,0.001 for
m2/p+ and p.0.05 for m+/p2). In the probe trial, analysis of platform crossing found that m+/p+ mice displayed a significantly biased searching
strategy, shown in E (p,0.001), while m2/p+ mice displayed a random searching strategy, shown in F (p.0.05). Post hoc analysis of m+/p+ mice
revealed that the difference was significant only between quadrant 4 and 2 (p,0.01), and quadrant 4 and 3 (p,0.02). The labeling of each quadrant
and location of the hidden platform is illustrated in G. * p,0.05.
doi:10.1371/journal.pone.0012278.g006
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expression in any tissue examined [12,13] but differs from a
third report suggesting predominant maternal expression of
Atp10a in hippocampus and olfactory bulb in mice [11]. It is not
immediately clear why the results from these studies are
different. One possibility is the effect of mouse genetic
background on imprinting, but this has not been fully
investigated [39]. Our expression analysis of Atp10a was
performed in mice with a relatively homogenous C57BL/6J
genetic background that overlaps with, but is not the same as
that used in the other studies. The technical limitations of the
different methods used should also be considered. Our strategy
of using Atp10a knockout mice was different from the other
studies, which used strain-specific single nucleotide polymor-
phisms to determine the parental origin of expression, or
studied in PWS imprinting center mutant mice. A limitation of
our analysis is that we could not rule out a cell type-specific
imprinting expression of Atp10a. In the future, expression
analysis by RNA in situ hybridization or immunohistochemistry
may help to determine if cell type-specific imprinting is
associated with Atp10a e x p r e s s i o n .S i m i l a r l y ,o u ra n a l y s i sd i d
not reveal any evidence for a parental origin of expression for
Gabrb3 but again the possibility of cell type or developmental
stage specific expression cannot be completely ruled out.
The function of Atp10a gene
The function of Atp10a in mammals is unknown. Homozygous
mice with a deletion from Ube3a to Gabrb3 d i e d1t o3d a y sa f t e r
birth and did not have any increased embryonic lethality or
additional structural defects compared to mice with a null
mutation of either Gabrb3 or Ube3a alone, or Gabrb3 and Ube3a
double mutation without a deletion (Jiang and Beaudet,
unpublished data). These observations suggest that the function
of Atp10a is probably not essential during embryonic develop-
ment. Studies of mice carrying a radiation-induced large
deletion proximal to the 39-end of Snrpn to the p locus that
included Atp10a, indicated that Atp10a may have an important
role in insulin resistance and glucose metabolism [40,41].
However, no direct conclusion regarding the role of Atp10a
could be made because the deletion is large and mice are
haploinsufficient for many genes in addition to Atp10a.I tw o u l d
be interesting to perform the experiment described by Dhar et
al. [40] to determine whether insulin resistance can also be
found in mice with the Ube3a to Gabrb3 deletion. Additional
studies of homozygous deletion mice and a careful comparison
to mice with null mutations of Ube3a or Gabrb3 in the region may
reveal the function of Atp10a, or it may be necessary to produce
an Atp10a single knockout in order to ultimately understand the
function of this gene.
Figure 7. Increased ultrasonic vocalizations (USVs) of newborn pups with a maternal deletion (m2/p+) from Ube3a to Gabrb3. A and
B. Comparison of m2/p+ and m+/p2 pups respectively to their m+/p+ littermates in different beddings. The m2/p+ pups emitted significantly more
USVs than that of m+/p+ littermates at mother’s bedding (p=0.006) (2B) but not for m+/p2 pups(2C, p.0.05). C. Comparison of USVs of m2/p+ to
m+/p+ at different postnatal days. The m2/p+ pups emitted more USVs overall than m+/p+ mice but this was only statistically significantly on day 10
(p=0.02) and day 12 (p=0.05). The three-way (genotype X bedding X day) with mixed design ANOVA did not reveal significant interaction among
them (p=0.07). Similarly, two-way ANOVA did not reveal significant interactions between genotype and bedding (p=0.15), and between genotype
and day (p=0.29). D. Comparison of USVs for m2/p+ and m+/p2 pups recorded in clean bedding at low temperature (4–6uC) on day 10 and day 12.
There was no significant difference between m2/p+ and their m+/p+ littermates (p=0.82), or between m+/p2 and their m+/p+ littermates (p=0.3).
*p ,0.05.
doi:10.1371/journal.pone.0012278.g007
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Ultrasonic vocalizations (USVs) in neonatal mice have been
studied both as early communicative behavior between pups and
mothers, and as a sign of response to environmental stress such as
separation and cold temperature [42]. Recording of USVs has
been increasingly used as a tool to analyze behavioral phenotypes
of mouse models of neurodevelopmental disorders although
interpretation of the findings remains a subject of debate [43].
Currently, there is no standardized protocol for recording USVs in
the literature [44]. We followed a previously described protocol
with minor modifications [45]. The rationale for recording USVs
on different beddings was based on the fact that different odors
may present important cues for social stress or isolation [42].
Recording in cold temperature was designed to evaluate the
response to a known stress for USV production [46]. The protocol
of recording on different days was based on the observation that
the peak of USV production varied on different postnatal days and
differed among different mouse genetic backgrounds [47]. From
reviewing the limited reports of USVs recording in knockout mice
in the literature, we anticipated the possibility that m2/p+ pups
might have reduced USVs because of absence of language and
autistic features in AS. Thus the finding of an overall increase in
USVs in pups with a maternal deletion from Ube3a to Gabrb3 was
somewhat unexpected but not surprised. The comparable rate of
USVs between m+/p+ and m2/p+ mice at cold temperature
suggested that m2/p+ pups had a normal response to cold stress.
The significantly increased production of USVs in different
beddings and on different days for m2/p+ pups may indicate
increased anxiety and response to social isolation stress. However,
this interpretation seems counterintuitive because the difference
between m+/p+ and m2/p+ was most significant in the mother’s
bedding which was intended to be less stressful because of the
maternal odor. Alternatively, the significant difference in USV
production between m+/p+ and m2/p+ pups recorded in the
mother’s bedding may reflect impairment related to maternal
attachment behaviors between mother and offspring. In the earlier
reports, the characteristic happy disposition and friendly behaviors
in AS patients were considered to be contextually inappropriate
and not related to the environment stimuli [18]. It has also been
reported that AS patients have significant autistic features and
often meet the diagnosis of autism spectrum disorder through
autism diagnostic evaluation [48,49]. In contrast, other recent
behavioral studies suggest that happy disposition like smiling and
laughing behaviors in AS were influenced by environmental clues
and different social settings [50,51]. By carefully observing social
behaviors among children with AS caused by a deletion of 15q11–
q13, Oliver et al. reported that AS patients smiled more and
evoked a higher level of adult attention than the control group in
different settings [51]. They concluded that the excessive smiling
and laughing behaviors seen in AS patients may indicate an
increase in signaling behaviors. Thus, the observation of increased
production of USVs in m2/p+ pups may suggest that increased
USVs is analogous to the increased signaling behaviors observed
in human AS. It should be noted that the human AS behavioral
observation studies by Oliver et al. were carried out only in a small
number of AS patients, all with a deletion of 15q11–q13 [51,52].
An interesting question is whether AS patients with mutations in
the UBE3A gene have the same behavioral profile related to
smiling and laughing as those with a deletion of 15q11–q13. With
the availability of AS mouse models with Ube3a mutation alone
and a deletion from Ube3a to Gabrb3 in this report, a similar
question can also be addressed in mice by recording USVs in both
AS mouse models and making a direct comparison. In addition,
recording the USVs in adult mice or using a different protocol in
newborn pups is also desirable to further characterize this
intriguing phenotype in future.
The value of recording and analyzing USVs to model human
autistic behaviors has been increasingly recognized, although the
interpretation of data and biological meaning of USVs in rodents
in relation to human behaviors is still a subject of debate [44,53].
Reduced USVs were reported in Foxp2 and Nlgn4 deficiency pups
[54,55,56,57]. These reports supported the value of this technique
because a mutation in the FOXP2 gene was implicated in a large
family with characteristic language disorder, and mutations in
NLGN4 have been found in a few cases of autism spectrum
disorders in humans [58,59]. On the other hand, similar to
maternal Ube3a to Gabrb3 deletion mice, increased USVs were
reported in Mecp2 deficiency pups, a mouse model of Rett
syndrome, in which autistic behavior is a major feature [60]. The
reason for increased USV in the Rett syndrome mouse model was
also not clear. There was a suggestion that the increased USVs
may be related abnormal respiratory function, a symptom
commonly observed in Rett syndrome patients [43]. Interestingly,
significant overlapping clinical features between AS and Rett
syndrome have long been documented [61]. Thus, the increased
USVs in both AS and Rett syndrome mouse models may suggest a
shared pathogenesis between these two disorders. In addition,
increased USVs in newborn pups was also reported in mice of
BTBR T+tf/J, tuberous sclerosis gene Tsc2 mutation, and paternal
duplication of human 15q11–q13 region [62,63,64]. These
observations suggest that increased USVs may be a common
feature in mutant mice related to autism.
A mouse model for a contiguous gene deletion form of
Angelman syndrome
Although the deletion from Ube3a to Gabrb3 is smaller than the
typical 6-Mb deletion frequently found in human AS patients, the
deleted interval in mice includes Ube3a, Atp10a, and Gabrb3 and
covers a critical region of AS deletion. Haploinsufficiency of
Atp10a and Gabrb3 has been suggested to account for differences in
the phenotypes between patients with a point mutation in UBE3A
and the large deletion form of AS. Thus, mice with a maternal
deletion from Ube3a to Gabrb3 are molecularly more similar to the
AS patients with a large maternal deletion of chromosome15q11–
q13. Our extensive behavioral characterization of both maternal
and paternal deletion mice supports that the maternal deletion
mouse is a valid model for the contiguous gene deletion form of
AS. The impairments in learning and memory tasks, including
contextual fear conditioning and Morris water maze, were specific
to maternal, but not paternal, deletion mice. Although both light-
dark and open field tests were used to evaluate anxiety related
behaviors, maternal deletion mice only displayed an impairment
in light-dark task but not in open field test. This may suggest a
selective deficit in anxiety related behavior in maternal deletion
mice. Although maternal deletion mice have significant impair-
ment in rotarod test, there was no difference for the travel distance
and speed in open field test. This was not a surprise because these
mice did not have apparent motor coordination problem and
abnormal gaits. The abnormal behaviors specific to the maternal
deletion mice are consistent with a brain-specific, maternal
expression pattern for the Ube3a gene. Mice used for these
behavioral tests were on a relatively homogenous C57BL/6J
genetic background after more than 6 generations of backcrossing
to C57BL/6J. This is generally acceptable for most behavioral
tests in the transgenic mutant mice although additional backcross-
ing may result more homogenous genetic background on C57BL/
6J [65]. It should also be noted that the genetic background of the
region most closely linked to the deletion at the Ube3a anchor is
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The genetic background of the region at the Gabrb3 anchor is
C57BL/6J because the targeting construct for Gabrb3 was
produced using a C57BL/6J genomic library. The different
genetic backgrounds at the targeted loci may influence the
expression of genes adjacent to the targeted region. While this is
technically difficult to investigate, the influence of these different
genetic backgrounds on observed behavioral differences between
maternal deletion mice and wild type littermate controls is
probably minimal. Behavioral data from mice with a maternal
Ube3a to Gabrb3 deletion are mostly consistent with previous
studies of Ube3a mutant mice, but the current study is more
extensive as summarized in Table 1[23,25,66]. Although muta-
tions in the UBE3A gene cause typical AS in humans, it has been
reported in some studies that the phenotypes such as seizures in AS
patients with UBE3A mutations are milder than in AS patients
with large deletions of 15q11–q13 [20,21,22]. In mice, we noticed
that the frequency of observed seizure activity was not significantly
different between deletion and Ube3a mutation mice [23].
However, these data should be interpreted with caution because
the seizure phenotype, at best, is only semi-quantifiable in mice.
More extensive studies with a novel design or technique are
needed to compare the seizure phenotype between mice with a
deletion and Ube3a mutation alone in order to make a meaningful
conclusion. Similarly, mice with a deletion from Ube3a to Gabrb3
provide a unique tool to compare other behavioral impairments
that observed in mice with Ube3a mutation alone. However, there
are potential issues in designing such comparative studies,
including that mice to be tested will have to be produced from
two different breeding and tests may not be carried out at the same
time in parallel because of the logistic support issues. Despite of
these challenges, these studies are worth to pursue because they
may help to elucidate the contribution of haploinsufficiency of
Gabrb3 and Atp10a in the pathogenesis of AS and further shed light
on the pathogenesis of human AS caused by different molecular
defects.
Materials and Methods
Ethics statement
All protocols involving animals in this work were approved by
the Institutional Animal Care and Use Committee of Baylor
College of Medicine and Duke University.
Targeting constructs for Ube3a and Gabrb3 genes
Two sets of overlapping lambda phage clones containing the
Ube3a and Gabrb3 genes were isolated from a mouse 129/SvEv and
C57BL/6J genomic library respectively. To place the loxP site at
the Ube3a locus, a replacement-type targeting vector of Ube3a-
pL13 was used to replace exon 2 of Ube3a with a cassette
containing a loxP site, a neomycin selectable marker, and a 59-half
of the Hprt exon 1 and 2 minigene. To place another loxP site at
the Gabrb3 locus, another replacement-type targeting vector of
Gabrb3-pG12 was constructed to replace part of exon 1 and exon 2
of Gabrb3 with a cassette containing a loxP site, a puromycin
selectable marker, and a 39-half of the Hprt exon 3 to 9 minigene.
The partial genomic and restriction enzyme map for the deleted
interval between Ube3a and Gabrb3, and cassettes are shown in
Figure 1A.
Generation of mice with a chromosomal deletion from
Ube3a to Gabrb3
To generate the ES cells with a deletion from Ube3a to Gabrb3,
the targeting construct for Gabrb3-pG12 was linearized with PvuI
restriction enzyme and electroporated into 1610
7 AB2.2 ES cells
from the 129/SvEv strain as previously described [23]. Puromycin
resistant colonies were picked after 7–8 days of selection. DNA
from ES cells was analyzed by mini-Southern blot hybridization
using both 59- and 39-flanking probes for the Gabrb3-pG12
construct to identify clones undergoing homologous recombina-
tion. The Gabrb3 targeted cells were expanded and used
subsequently for targeting of the Ube3a gene. The Ube3a-pL13
construct linearized with NotI restriction was electroporated into
Table 1. Comparison of phenotypes in Angelman syndrome mouse models with different mutations.
Features Ube3a m2/p+(Jiang*) Ube3a m2/p+(Miura
#) Deletion m2/p+
"
General appearance no abnormality No abnormality no abnormality
Expression of Ube3a in brains maternal maternal maternal
Hot plate test n/a n/a no abnormality
Light-dark n/a n/a impaired
Open field n/a n/a no abnormality
Rotarod Impaired Impaired impaired
PPI n/a n/a no abnormalities
Fear conditioning impaired impaired impaired
Morris water maze test impaired impaired impaired
USVs n/a n/a increased
Synaptic plasticity hippocampal long- term potentiation defect n/a n/a
EEG abnormal abnormal abnormal
Seizures yes n/a yes
*: Targeting construct disrupted exon 2 (corresponding to human UBE3A exon sequence of GenBank accession No. X98022). Data are summarized from original
publication[23] and subsequent studies[66,70]
#: Targeting construct disrupted part of exon 15 and exon 16 (corresponding to human UBE3A exon sequence of GenBank accession No. AF009341)[25].
": entire Ube3a gene was disrupted and also Gabrb3 and Atp10a (this report)
n/a: not analyzed
doi:10.1371/journal.pone.0012278.t001
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described except that neomycin was used for selection. The Gabrb3
and Ube3a double targeted ES cells were identified and subjected
to electroporation with a Cre recombinase (pOG231) plasmid.
HAT (hypoxanthine and thymine) selection was applied to select
ES cells undergoing recombination between loxP sites to join the
two halves of the Hprt minigene that conferred the HAT
resistance. Abundant HAT-resistant clones were obtained from 2
out of 4 independent double-targeted ES clones, and these were
further subjected to sib selection using puromycin or neomycin to
determine the possible configuration of cis or trans recombination
mediated by Cre recombinase. A total of 16 HAT resistant clones
were sensitive to both puromycin and neomycin, indicating that
the targeting was in cis and Cre-mediated recombination between
loxP sites occurred as described previously [36]. ES cells with
Gabrb3 targeted, Gabrb3 and Ube3a double-targeted, and a deletion
from Gabrb3 to Ube3a were in injected into C57 BL/6J blastocysts
for germline transmission.
Mouse breeding, genotyping, and backcrossing
Mice carrying the deletion from Ube3a to Gabrb3 were
backcrossed to C57BL/6J for more than 6 generations. Because
of genomic imprinting in the region, a specific breeding scheme
(Figure S4) was followed to produce mice for molecular studies and
behavioral tests. Heterozygous males were bred to wild type
C57BL/6J females to produce heterozygotes with a paternal
deletion from Ube3a to Gabrb3 (m+/p2) and wild type littermates
(m+/p+). Heterozygous females were bred to wild type C57BL/6J
males to produce heterozygotes with a maternal deletion from
Ube3a to Gabrb3 (m2/p+) and wild type littermates (m+/p+).
Because of a possible role of maternal factors in production of
ultrasonic vocalization (USV) in offspring, newborn pups used for
the USV recording were produced by using male or female
heterozygotes that had a deletion paternally but not maternally.
Homozygotes with a deletion from Ube3a to Gabrb3 (m2/p2)
were produced by crossing heterozygous mice with a deletion. All
experimentation and animal husbandry involving animals in this
report have been conducted according to relevant national and
international guidelines and under the animal protocols approved
by IACUC at Duke University and Baylor College of Medicine.
Genotyping was routinely doing by PCR based method using the
following primer pairS: UB-R:59 ATT AGA GGT GAT GAG
GGT ATT GAG; UB-F:59 CAT TGC AAA TCA AAG GTG
TGT GGA; pL13:59 TAC TTC CAT TTG TCA CGT CCT
GCA C. PCR condition is as following: denaturation at 94uC for
45 seconds, annealing at 52uC for 45 seconds, and extension at
62uC for 45 seconds, for 35 cycles, and followed by a 5 min
extension period at 72uC
RNA isolation and RNA expression analysis
Total RNA was isolated using the Trizol method as previously
described [23]. For RT-PCR analysis, DNase I-treated total RNA
was reverse transcribed with Superscript RNase H
2 reverse
transcriptase (Invitrogen, Carlsbad CA) using random hexamers
for Atp10a. PCR was carried out in 50 ml reactions with cycling
conditions of denaturation at 94uC for 45 seconds, annealing at
62uC for 45 seconds, and extension at 62uC for 45 seconds, for 35
cycles. The final cycle was followed by a 5 min extension period at
72uC. Primers were ATP10AF: 59- CTTGTCTTCAGCAGG-
GAAAAG-39 and ATP10R: 59- AATGAGTAAACTGGTGT
GGGT-39. For real-time quantitative RT-PCR using LightCycler
Hydrolysis probes, the primers used were ATP10aRealT-F: 59-
ATGAAATCAACCACCTGGG-39 and ATP10aRealT-R: 59-
TTCAGGTTGGTCTCT CCAT-39. The probe used was 59
FAM-CGACTTTGTCCGTCTTTGCTGCAATG-BHQ-1 39.
Primers and probe for mouse b-actin were provided by Roche
(Roche applied science, Germany). Real-time quantitative PCR
was carried out using a LightCycler 480 Instrument (Roche
Diagnostics, Germany) and LightCycler 480 RNA Master
Hydrolysis Probes following manufacturer’s recommendations.
Two ml of the total RNA sample was used in a 20 ml PCR reaction
containing 1x LightCycler 480 RNA master mix with an
appropriate concentration of primers and probe. All samples
and experiments were run in triplicate. Each PCR run also
included 3 samples without RNA template as negative controls as
well as a consistent triplicate calibrator comprising a mixture of
multiple mouse cerebellum RNA as template. Mouse b-actin RNA
expression was used as an internal reference to normalize the
quantity of RNA input across samples for quantification analysis.
Western blot analysis
Mouse brain tissues were homogenized in NP40/SDS buffer
(1% Nonidet P-40, 0.01% SDS, 0.1 M Tris-HCl, pH 7.2, and
complete Protease Inhibitor Cocktail Tablet; Roche Applied
Sciences, Indianapolis, IN) on ice with a pellet pestle. Following
polyacryl amide gel electrophoresis, proteins were transferred to
nitrocellulose membrane (Bio-Rad; Hercules, CA) at 4uC
overnight. Incubations with antibodies were performed in TPBS-
milk at 4uC overnight as follows: rabbit anti-human E6-AP diluted
1:1,000 (BL447; Bethyl Labs, Montgomery, TX); mouse Gabrb3
diluted 1:500 (LC-43101, Santa Cruz Biotec, Santan Cruz CA);
and anti-mouse actin diluted 1:500 (SC-1606, Santa Cruz Biotec.
Santa Cruz, CA). The signals were detected by enhanced
chemiluminescence (ECL, Amersham Life Science, Newark, NJ).
The Image J software was used for quantification.
Chronic electroencephalographic (EEG) recordings
Paternal and maternal deletion mice and wild-type littermates
(aged 3–4 months) were implanted for chronic EEG monitoring.
Mice were anesthetized with Avertin (1.25% tribromoethanol/
amyl alcohol solution, i.p.) using a dose of 0.02 ml/g. Teflon-
coated silver wire electrodes (0.005 inch diameter) attached to a
microminiature connector were implanted bilaterally into the
subdural space over temporal, parietal, and occipital cortices.
Digital EEG activity was monitored daily for up to two weeks
during prolonged overnight and random 2 hr sample recordings
(Stellate Systems, Harmonie software version 6.1b; Montreal
Quebec, Canada). A digital video camera was used to simulta-
neously monitor behavior during the EEG recording periods. All
recordings were carried out at least 24 hours after surgery on mice
freely moving in the test cage.
Mouse behavioral testing
A battery of behavioral test was performed using a protocol
previously described and used in behavioral core facilities at
Baylor College of Medicine [23,67,68]. These tests include open
field, light dark, rotarod, prepluse inhibition (PPI), fear condition-
ing, Morris water maze, hot plate, and ultrasonic vocalization
recording (USVs). Mice were tested in the order listed except
USVs for which a different set of mice were used. Mice were rested
for one week between each test except only 1–3 days between open
field and light dark and two to three weeks between fear
conditioning and Morris water maze. The procedure and
sequence of the tests, except of USVs recording, were previously
described and validated [67,68,69]. A different set of newborn
pups was used for the USVs recording and these pups were not be
used for other behavioral tests. The protocol for USVs recording
was based on a previous report with minor modifications [45]. A
Altered Ultrasonic
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mentary data, Method S1.
Statistical analysis
Raw data from all behavioral tests were documented and
tabulated in Microsoft excel. Statistical analyses were performed
using Origin 8 software (http://www.originlab.com/) and SAS
(www.sas.com) packages. For most behavioral data, analyses were
performed by using one-way ANOVA. Two-way and three-way
ANOVA with repeated measure was used as indicated. Post hoc
analysis was also performed as indicated.
Supporting Information
Figure S1 Open field and hot plate test. A, B, C: Results of open
filed test. Travel distance per block for m2/p+ (A) and m+/p2
(B), as well as total travel distance (C) of m2/p+ and m+/p2 mice
in open field test. D. Results of hot plate test.
Found at: doi:10.1371/journal.pone.0012278.s001 (0.02 MB
PDF)
Figure S2 Results of Pre-pulse inhibition in mice. No difference
in maximal startle response between m2/p+ mice and their m+/
p+ littermates or between m+/p2 mice and their m+/p+
littermates.
Found at: doi:10.1371/journal.pone.0012278.s002 (0.01 MB
PDF)
Figure S3 The production of USVs of maternal deletion pups in
different days and beddings.
Found at: doi:10.1371/journal.pone.0012278.s003 (0.02 MB
PDF)
Figure S4 Breeding of Ube3a and Gabrb3 deletion mice. Only F1
and F2 are diagrammed in figure. Mice and pups used for the
experiments were from .F6 of backcrossing to C57BL/6J.
Found at: doi:10.1371/journal.pone.0012278.s004 (0.02 MB
PDF)
Method S1 Protocols for behavioral testing.
Found at: doi:10.1371/journal.pone.0012278.s005 (0.04 MB
DOC)
Video S1 EEG recording video.
Found at: doi:10.1371/journal.pone.0012278.s006 (16.39 MB
ZIP)
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